Abstract：Objective To study the types and characteristics of TUBB1 mutation in children with congenital hypothyroidism (CH) and thyroid dysgenesis (TD) in Shandong, China. Methods Mutations of the whole coding region of the TUBB1 gene were analyzed for 289 children with CH and TD in Shandong. Whole-genome DNA was extracted from peripheral blood leukocytes. PCR multiplication was performed for the whole coding region of the TUBB1 gene. Sanger sequencing was performed for the PCR products, and a biological information analysis was performed. Results Among the 289 children with CH and TD, 4 (1.4%) were found to have a c.952C > T(p.R318W) heterozygous mutation in the TUBB1 gene, resulting in the change of tryptophan into arginine at codon 318 of TUBB1 protein. This mutation was evaluated as "potentially pathogenic" based on the classification criteria and guidelines for genetic variation by American College of Medical Genetics and Genomics. Conclusions A novel mutation is detected in the exon of the TUBB1 gene in children with CH and TD in Shandong, suggesting that the TUBB1 gene may be a candidate pathogenic gene for CH children with TD.
SUN Chun-Hui,LIU Wen-Miao,LI Miao-Miao et al. TUBB1 mutation in children with congenital hypothyroidism and thyroid dysgenesis in Shandong, China[J]. CJCP, 2019, 21(10): 972-976.
Deladoëy J, Bélanger N, Van Vliet G. Random variability in congenital hypothyroidism from thyroid dysgenesis over 16 years in Québec[J]. J Clin Endocrinol Metab, 2007, 92(8):3158-3161.
[2]
Fan X, Fu C, Shen Y, et al. Next-generation sequencing analysis of twelve known causative genes in congenital hypothyroidism[J]. Clin Chim Acta, 2017, 468:76-80.
[3]
Mitchell ML, Hsu HW, Sahai I, et al. The increased incidence of congenital hypothyroidism:fact or fancy?[J]. Clin Endocrinol (Oxf), 2011, 75(6):806-810.
[4]
Leunbach TL, Christensen PS, Kristensen K. The incidence of congenital hypothyroidism is increasing[J]. Ugeskr Laeger, 2017, 179(26). pii:V11160859.
[5]
Fu C, Luo S, Li Y, et al. The incidence of congenital hypothyroidism (CH) in Guangxi, China and the predictors of permanent and transient CH[J]. Endocr Connect, 2017, 6(8):926-934.
[6]
Kollati Y, Ambati RR, Reddy PN, et al. Congenital hypothyroidism:facts, facets&therapy[J]. Curr Pharm Des, 2017, 23(16):2308-2313.
Kumorowicz-Czoch M, Tylek-Lemanskaz D, Wyrobek L, et al. Thyroid developmental anomalies among first-degree relatives of children with thyroid dysgenesis and congenital hypothyroidism[J]. J Pediatr Endocrinol Metab, 2012, 25(5-6):413-418.
[10]
Adibi A, Haghighi M, Hosseini SR, et al. Thyroid abnormalities among first-degree relatives of children with congenital hypothyroidism:an ultrasound survey[J]. Horm Res, 2008, 70(2):100-104.
[11]
Qian F, Li GY, Wu XJ, et al. Novel non-synonymous mutations of PAX8 in a cohort of Chinese with congenital hypothyroidism[J]. Chin Med J (Engl), 2019, 132(11):1322-1327.
[12]
Kumorowicz-Czoch M, Madetko-Talowska A, Dudek A, et al. Genetic analysis of the paired box transcription factor (PAX8) gene in a cohort of Polish patients with primary congenital hypothyroidism and dysgenetic thyroid glands[J]. J Pediatr Endocrinol Metab, 2015, 28(7-8):735-743.
[13]
Hermanns P, Kumorowicz-Czoch M, Grasberger H, et al. Novel mutations in the NKX2.1 gene and the PAX8 gene in a boy with brain-lung-thyroid syndrome[J]. Exp Clin Endocrinol Diabetes, 2018, 126(2):85-90.
[14]
Wang F, Liu C, Jia X, et al. Next-generation sequencing of NKX2.1, FOXE1, PAX8, NKX2.5, and TSHR in 100 Chinese patients with congenital hypothyroidism and athyreosis[J]. Clin Chim Acta, 2017, 470:36-41.
[15]
Peters C, van Trotsenburg ASP, Schoenmakers N. Diagnosis of endocrine disease:congenital hypothyroidism:update and perspectives[J]. Eur J Endocrinol, 2018, 179(6):R297-R317.
[16]
Jeon K, Kumar D, Conway AE, et al. GLIS3 transcriptionally activates WNT genes to promote differentiation of human embryonic stem cells into posterior neural progenitors[J]. Stem Cells, 2019, 37(2):202-215.
[17]
Stoupa A, Adam F, Kariyawasam D, et al. TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology[J]. EMBO Mol Med, 2018, 10(12). pii:e9569.
[18]
Gardner JF, Cushion TD, Niotakis G, et al. Clinical and functional characterization of the recurrent TUBA1A p.(Arg2His) mutation[J]. Brain Sci, 2018, 8(8). pii:E145.
[19]
Gadadhar S, Bodakuntla S, Natarajan K, et al. The tubulin code at a glance[J]. J Cell Sci, 2017, 130(8):1347-1353.
[20]
Prosser SL, Pelletier L. Mitotic spindle assembly in animal cells:a fine balancing act[J]. Nat Rev Mol Cell Biol, 2017, 18(3):187-201.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
[23]
Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics[J]. Annu Rev Cell Dev Biol, 2000, 16:89-111.
[24]
Stoupa A, Kariyawasam D, Carré A, et al. Update of thyroid developmental genes[J]. Endocrinol Metab Clin North Am, 2016, 45(2):243-254.
[25]
Nilsson M, Fagman H. Development of the thyroid gland[J]. Development, 2017, 144(12):2123-2140.
[26]
Szinnai G, Lacroix L, Carré A, et al. Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus[J]. J Clin Endocrinol Metab, 2007, 92(1):70-76.
[27]
Fernández LP, López-Márquez A, Santisteban P. Thyroid transcription factors in development, differentiation and disease[J]. Nat Rev Endocrinol, 2015, 11(1):29-42.
[28]
Carré A, Stoupa A, Kariyawasam D, et al. Mutations in BOREALIN cause thyroid dysgenesis[J]. Hum Mol Genet, 2017, 26(3):599-610.
